Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $597.99M.
ENTERPRISE VALUE (EV)
$597.99M
Aura Biosciences, Inc.
Market Cap
$643.37M
Enterprise Value (EV)
$597.99M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aura Biosciences, Inc. (AURA) | $643.37M | $597.99M |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | $588.44M |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | $620.71M |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | $589.96M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | $644.25M |
| Annexon, Inc. (ANNX)vs › | $688.14M | $513.52M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | $577.20M |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | $672.29M |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | $507.87M |
| Helus Pharma Inc. (HELP)vs › | $707.86M | $541.69M |
Market Cap
$643.37M
Total Debt
$14.13M
Cash
$59.52M
Enterprise Value
$597.99M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
